AVAH Stock: Price, Earnings History and SEC Filings
Aveanna Healthcare Holdings Inc. (AVAH) last traded at $13.16, down 0.75% on the latest session and up 6.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.21 against an analyst estimate of $0.16, a beat of 31.2%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
AVAH earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 13, 2026 | $0.21 | $0.16 | +31.25% |
| Mar 2026 | May 14, 2026 | $0.17 | $0.12 | +41.67% |
| Dec 2025 | Mar 19, 2026 | $0.16 | $0.10 | +60.00% |
| Sep 2025 | Nov 6, 2025 | $0.12 | $0.06 | +100.00% |
AVAH beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How AVAH reacts to earnings
Across its last 8 earnings releases, AVAH moved 16.3% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-13 | Before open | +24.75% |
| 2026-05-14 | Before open | +9.90% |
| 2026-03-19 | Before open | -8.25% |
| 2026-01-14 | Before open | +10.01% |
| 2025-11-06 | Before open | -6.30% |
| 2025-10-21 | After close | -7.38% |
| 2025-08-07 | Before open | +49.36% |
| 2025-05-08 | Before open | +14.11% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
AVAH financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | $2.4B | $225M | – | 9.2% | $1.05 |
| 2024 | $2.0B | -$11M | – | -0.5% | $-0.06 |
| 2023 | $1.9B | -$135M | – | -7.1% | $-0.71 |
| 2022 | $1.8B | -$662M | -$64M | -37.0% | $-3.57 |
| 2021 | $1.5B | -$57M | $101M | -3.8% | – |
| 2019 | $1.4B | -$77M | -$25M | -5.5% | – |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for AVAH
- 8-K · Oct 2, 2026Officer or director change
- 8-K · Aug 24, 2026Other events, Financial statements and exhibits
- 424B4 · Aug 24, 2026
- 424B4 · Aug 20, 2026
- 10-Q · Aug 13, 2026
- 8-K · Aug 13, 2026Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 13, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 7, 2026Officer or director change
- 8-K · Jun 2, 2026Other events, Financial statements and exhibits
- 8-K · May 29, 2026Shareholder vote
Insider filing activity
AVAH insiders filed 7 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
AVAH news
- Chemed (CHE) Tops Q3 Earnings and Revenue EstimatesOct 27, 2026 · finance.yahoo.com
- Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?Oct 27, 2026 · finance.yahoo.com
- Aveanna Announces Third Quarter 2026 Earnings Release Date and Conference CallOct 22, 2026 · finance.yahoo.com
About Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc. (AVAH) is a US-listed public company on Nasdaq. The SEC classifies its business as Services-home Health Care Services. It is incorporated in DE. Its fiscal year ends in January.